Latest News:

ar deelen fr it

TIF

TIF will coordinate efforts for patients’ information on Reblozyl in 62 countries

A new and encouraging chapter is finally opening up for patients with thalassaemia, following the re...
New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019

Celgene Corporation, Acceleron Pharma, Sangamo Therapeutics & Agios Pharmaceuticals are e...
Deferasirox Mylan: A new generic drug for the treatment of iron overload in β-thalassaemia major obtained approval by the EMA

The European Medicines Agency’s (EMA) has recently granted marketing authorisation for ...
High-Level Thalassaemia & Sickle Cell Disease Healthcare Professionals Summit – 1 & 2 November 2019

After the successful Capacity Building Workshop for Patient Organizations & Patients with thalas...
US government & Gates Foundation pledge $200 million to bring gene therapies to patients with Sickle Cell Disease & HIV

The National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation will each...

Highlights

TIF e-AcademyAcadémie électronique de la FITe-Academyالأكاديمية الإلكترونية للاتحاد الدولي للثلاسيمياΗλεκτρονική ΑκαδημίαTIF e-Akademie

Patients' StoriesRécits de patientsStorie di pazientiقصص المرضىΙστορίες ΑσθενώνErfahrungsberichte von Patienten

Clinical Trial UpdatesEssais cliniques - Mises à jourAggiornamenti sugli studi cliniciآخر مستجدات التجارب الإكلينكية Ενημερώσεις για κλινικές δοκιμέςUpdate zu klinischen Studien

Renzo Galanello FellowshipsBourses Renzo GalanelloBorsa di studio Renzo Galanelloمنحة رينزو جالانيلوΥποτροφίες Renzo GalanelloRenzo Galanello Stipendien

International Thalassaemia DayJournée Mondiale de la ThalassémieGiornata internazionale della talassemiaاليوم العالمي ’للثلاسيميا’Παγκόσμια Ημέρα ΘαλασσαιμίαςInternationaler Tag der Thalassämie

The THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA Project

This is the informative poster we've prepared to describe #TIF's work and achievements in the framework of the… https://t.co/lbnm2p3cUY 21 ώρες πριν
5 Facts you should know about #SickleCell Disease in a single infographic, created by the @CDCgov. #TIF #SCD… https://t.co/K9tEYTpFBE 12/11/2019
#FDA Approves REBLOZYL® (Luspatercept) for the Treatment of Anaemia in Adults With β-#Thalassaemia Who Require Regu… https://t.co/AZews96W8K 12/11/2019
#FlashbackFriday @thalassaemiaTIF Take a journey with us back in 2001 through several photos 📸📸 from two… https://t.co/MF5dGdONJh 08/11/2019

Supporters Sympathisants Sostenitori الداعمون Οι Υποστηρικτές μας Unterstützer